aluates Reports

$ 0.0

Automative

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-14F12248

Global Porcine Reproductive Respiratory Syndrome PRRS Vaccines Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14F12248

Report

September 2024

Pages:144

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CAHIC

MSD Animal Health

Ceva

ChengDu Tecbond

Ringpu Biology

Qilu Animal

DHN

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Tecon

Zoetis Inc

Boehringer Ingelheim

Sino Pharm

Phibro Animal Health

WINSUN

PULILE

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market Size

The global market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines was estimated to be worth US$ 363 million in 2023 and is forecast to a readjusted size of US$ 696.7 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market

There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.

Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by region & country, by Type, and by Application.

The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.

Market Segmentation

Scope of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market Report

Report Metric	Details
Report Name	Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market
Forecasted market size in 2030	US$ 696.7 million
CAGR	10.2%
Forecasted years	2024 - 2030
Segment by Type:	Live Vaccines Killed Vaccines
Segment by Application	Government Tender Market Sales
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CAHIC, Boehringer Ingelheim, MSD Animal Health, Sino Pharm, Ceva, ChengDu Tecbond, Ringpu Biology, Qilu Animal, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Phibro Animal Health, Tecon, Zoetis, WINSUN, PULILE
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market size in 2030?

Ans: The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market size in 2030 will be US$ 696.7 million.

Who are the main players in the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market report?

Ans: The main players in the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market are CAHIC, Boehringer Ingelheim, MSD Animal Health, Sino Pharm, Ceva, ChengDu Tecbond, Ringpu Biology, Qilu Animal, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Phibro Animal Health, Tecon, Zoetis, WINSUN, PULILE

What are the Application segmentation covered in the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market report?

Ans: The Applications covered in the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market report?

Ans: The Types covered in the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines - Market report are Live Vaccines, Killed Vaccines

Recommended Reports

Porcine and Livestock Vaccines

Respiratory Viral Vaccines

Animal Disease Vaccines

1 Market Overview

1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Introduction

1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast

1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2019-2030)

1.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume (2019-2030)

1.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price (2019-2030)

1.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Trends & Drivers

1.3.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends

1.3.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers & Opportunity

1.3.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges

1.3.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Revenue Ranking (2023)

2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2019-2024)

2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Sales Volume Ranking (2023)

2.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Company Players (2019-2024)

2.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Company (2019-2024)

2.6 Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

2.9 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Analysis

2.9.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Live Vaccines

3.1.2 Killed Vaccines

3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type

3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, by Type (2019-2030)

3.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, by Type (%) (2019-2030)

3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type

3.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume, by Type (2019-2030)

3.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume, by Type (%) (2019-2030)

3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Government Tender

4.1.2 Market Sales

4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application

4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, by Application (2019-2030)

4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, by Application (%) (2019-2030)

4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application

4.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume, by Application (2019-2030)

4.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume, by Application (%) (2019-2030)

4.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region

5.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2019-2024)

5.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2025-2030)

5.1.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (%), (2019-2030)

5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region

5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region (2019-2024)

5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region (2025-2030)

5.2.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region (%), (2019-2030)

5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

5.4.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

5.5.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

5.6.2 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

5.7.2 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

5.8.2 Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value

6.2.1 Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

6.2.2 Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

6.3.2 United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

6.4.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

6.5.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

6.5.3 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

6.6.2 Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

6.7.2 South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

6.8.2 Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019-2030

6.9.2 India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

6.9.3 India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 CAHIC

7.1.1 CAHIC Company Information

7.1.2 CAHIC Introduction and Business Overview

7.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.1.5 CAHIC Recent Development

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim Company Information

7.2.2 Boehringer Ingelheim Introduction and Business Overview

7.2.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.2.5 Boehringer Ingelheim Recent Development

7.3 MSD Animal Health

7.3.1 MSD Animal Health Company Information

7.3.2 MSD Animal Health Introduction and Business Overview

7.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.3.5 MSD Animal Health Recent Development

7.4 Sino Pharm

7.4.1 Sino Pharm Company Information

7.4.2 Sino Pharm Introduction and Business Overview

7.4.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.4.5 Sino Pharm Recent Development

7.5 Ceva

7.5.1 Ceva Company Information

7.5.2 Ceva Introduction and Business Overview

7.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.5.5 Ceva Recent Development

7.6 ChengDu Tecbond

7.6.1 ChengDu Tecbond Company Information

7.6.2 ChengDu Tecbond Introduction and Business Overview

7.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.6.5 ChengDu Tecbond Recent Development

7.7 Ringpu Biology

7.7.1 Ringpu Biology Company Information

7.7.2 Ringpu Biology Introduction and Business Overview

7.7.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.7.5 Ringpu Biology Recent Development

7.8 Qilu Animal

7.8.1 Qilu Animal Company Information

7.8.2 Qilu Animal Introduction and Business Overview

7.8.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.8.5 Qilu Animal Recent Development

7.9 DHN

7.9.1 DHN Company Information

7.9.2 DHN Introduction and Business Overview

7.9.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.9.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.9.5 DHN Recent Development

7.10 CAVAC

7.10.1 CAVAC Company Information

7.10.2 CAVAC Introduction and Business Overview

7.10.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.10.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.10.5 CAVAC Recent Development

7.11 Komipharm

7.11.1 Komipharm Company Information

7.11.2 Komipharm Introduction and Business Overview

7.11.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.11.5 Komipharm Recent Development

7.12 Agrovet

7.12.1 Agrovet Company Information

7.12.2 Agrovet Introduction and Business Overview

7.12.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.12.5 Agrovet Recent Development

7.13 Bioveta

7.13.1 Bioveta Company Information

7.13.2 Bioveta Introduction and Business Overview

7.13.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.13.5 Bioveta Recent Development

7.14 Jinyu Bio-Technology

7.14.1 Jinyu Bio-Technology Company Information

7.14.2 Jinyu Bio-Technology Introduction and Business Overview

7.14.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.14.5 Jinyu Bio-Technology Recent Development

7.15 Phibro Animal Health

7.15.1 Phibro Animal Health Company Information

7.15.2 Phibro Animal Health Introduction and Business Overview

7.15.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.15.5 Phibro Animal Health Recent Development

7.16 Tecon

7.16.1 Tecon Company Information

7.16.2 Tecon Introduction and Business Overview

7.16.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.16.5 Tecon Recent Development

7.17 Zoetis

7.17.1 Zoetis Company Information

7.17.2 Zoetis Introduction and Business Overview

7.17.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.17.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.17.5 Zoetis Recent Development

7.18 WINSUN

7.18.1 WINSUN Company Information

7.18.2 WINSUN Introduction and Business Overview

7.18.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.18.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.18.5 WINSUN Recent Development

7.19 PULILE

7.19.1 PULILE Company Information

7.19.2 PULILE Introduction and Business Overview

7.19.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.19.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

7.19.5 PULILE Recent Development

8 Industry Chain Analysis

8.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain

8.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Model

8.5.2 Sales Channel

8.5.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

CAHIC

MSD Animal Health

Ceva

ChengDu Tecbond

Ringpu Biology

Qilu Animal

DHN

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Tecon

Zoetis Inc

Boehringer Ingelheim

Sino Pharm

Phibro Animal Health

WINSUN

PULILE

List of Tables

Table 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Trends

Table 2. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers & Opportunity

Table 3. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges

Table 4. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints

Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Company (2019-2024)

Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Company (2019-2024) & (M Units)

Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Company (2019-2024) & (USD/K Unit)

Table 10. Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)

Table 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2019-2024) & (M Units)

Table 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2025-2030) & (M Units)

Table 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2019-2024) & (USD/K Unit)

Table 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2025-2030) & (USD/K Unit)

Table 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)

Table 34. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2019-2024) & (M Units)

Table 35. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2025-2030) & (M Units)

Table 36. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2019-2024) & (USD/K Unit)

Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2025-2030) & (USD/K Unit)

Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2019-2024) & (%)

Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Region (2025-2030) & (%)

Table 45. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region (M Units): 2019 VS 2023 VS 2030

Table 46. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region (2019-2024) & (M Units)

Table 47. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region (2025-2030) & (M Units)

Table 48. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region (2019-2024) & (%)

Table 49. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Region (2025-2030) & (%)

Table 50. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Region (2019-2024) & (USD/K Unit)

Table 51. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Region (2025-2030) & (USD/K Unit)

Table 52. Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume, (2019-2024) & (M Units)

Table 56. Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume, (2025-2030) & (M Units)

Table 57. CAHIC Company Information

Table 58. CAHIC Introduction and Business Overview

Table 59. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 60. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 61. CAHIC Recent Development

Table 62. Boehringer Ingelheim Company Information

Table 63. Boehringer Ingelheim Introduction and Business Overview

Table 64. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 65. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 66. Boehringer Ingelheim Recent Development

Table 67. MSD Animal Health Company Information

Table 68. MSD Animal Health Introduction and Business Overview

Table 69. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 70. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 71. MSD Animal Health Recent Development

Table 72. Sino Pharm Company Information

Table 73. Sino Pharm Introduction and Business Overview

Table 74. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 75. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 76. Sino Pharm Recent Development

Table 77. Ceva Company Information

Table 78. Ceva Introduction and Business Overview

Table 79. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 80. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 81. Ceva Recent Development

Table 82. ChengDu Tecbond Company Information

Table 83. ChengDu Tecbond Introduction and Business Overview

Table 84. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 85. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 86. ChengDu Tecbond Recent Development

Table 87. Ringpu Biology Company Information

Table 88. Ringpu Biology Introduction and Business Overview

Table 89. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 90. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 91. Ringpu Biology Recent Development

Table 92. Qilu Animal Company Information

Table 93. Qilu Animal Introduction and Business Overview

Table 94. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 95. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 96. Qilu Animal Recent Development

Table 97. DHN Company Information

Table 98. DHN Introduction and Business Overview

Table 99. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 100. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 101. DHN Recent Development

Table 102. CAVAC Company Information

Table 103. CAVAC Introduction and Business Overview

Table 104. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 105. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 106. CAVAC Recent Development

Table 107. Komipharm Company Information

Table 108. Komipharm Introduction and Business Overview

Table 109. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 110. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 111. Komipharm Recent Development

Table 112. Agrovet Company Information

Table 113. Agrovet Introduction and Business Overview

Table 114. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 115. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 116. Agrovet Recent Development

Table 117. Bioveta Company Information

Table 118. Bioveta Introduction and Business Overview

Table 119. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 120. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 121. Bioveta Recent Development

Table 122. Jinyu Bio-Technology Company Information

Table 123. Jinyu Bio-Technology Introduction and Business Overview

Table 124. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 125. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 126. Jinyu Bio-Technology Recent Development

Table 127. Phibro Animal Health Company Information

Table 128. Phibro Animal Health Introduction and Business Overview

Table 129. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 130. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 131. Phibro Animal Health Recent Development

Table 132. Tecon Company Information

Table 133. Tecon Introduction and Business Overview

Table 134. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 135. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 136. Tecon Recent Development

Table 137. Zoetis Company Information

Table 138. Zoetis Introduction and Business Overview

Table 139. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 140. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 141. Zoetis Recent Development

Table 142. WINSUN Company Information

Table 143. WINSUN Introduction and Business Overview

Table 144. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 145. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 146. WINSUN Recent Development

Table 147. PULILE Company Information

Table 148. PULILE Introduction and Business Overview

Table 149. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)

Table 150. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offerings

Table 151. PULILE Recent Development

Table 152. Key Raw Materials Lists

Table 153. Raw Materials Key Suppliers Lists

Table 154. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Downstream Customers

Table 155. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

List of Figures

Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Picture

Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume (2019-2030) & (M Units)

Figure 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price (2019-2030) & (USD/K Unit)

Figure 6. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Report Years Considered

Figure 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Sales Volume Ranking (2023) & (M Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue in 2023

Figure 10. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Live Vaccines Picture

Figure 12. Killed Vaccines Picture

Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)

Figure 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2019-2030) & (USD/K Unit)

Figure 18. Product Picture of Government Tender

Figure 19. Product Picture of Market Sales

Figure 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)

Figure 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2019-2030) & (USD/K Unit)

Figure 25. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Volume (%), (2019-2030)

Figure 37. United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 43. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 45. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 55. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 57. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 58. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain

Figure 59. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Vaccine for Porcine Reproductive and Respiratory Syndrome PRRS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PRRS Vaccines Market Research Report 2024

Global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine Live Market Research Report 2025

Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Insights Forecast to 2030

Porcine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Swine Parvovirus Disease Vaccine Market Research Report 2024

Duck Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Vaccine for Swine Mycoplasma Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Porcine Circovirus Diseases Vaccine Market Research Report 2024

Global Respiratory Virus Vaccines Market Research Report 2024

Swine Influenza Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chicken Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Mycoplasma Pneumonia Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024

Vaccines and Drugs for Duck Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PRRS Test Kit Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions